Corporate Clients

Realise potential, meet goals, and build value.

Results works as a trusted adviser to corporate clients, including some of the world’s leading pharmaceutical companies. Our clients know they can count on our track-record, depth of experience, professionalism and exceptional technical capabilities.

We work closely with corporate clients that need sector specialist advisors for their buy-side or sell-side M&A needs. Our solutions include strategic reviews of business or facility portfolios, support for acquisitions and divestments, as well as advising on licensing transactions for marketed products.

Commitment to client service is a hallmark of our project teams.

Our disciplined approach and strong technical capability allow our corporate clients to execute projects with confidence and achieve their strategic goals.

We pride ourselves on our integrity and straight talking, giving the best advice to our clients. We are focused on getting the best outcome: we think this demands an adviser who will be clear and considered however complex or pressurised the situation.

David Sanders

Managing Director

Services

We’ve been providing independent M&A and corporate finance advice and execution services to entrepreneurs, corporates and investors in the technology and healthcare sectors for over 30 years. Whether your aim is to realise value or to find a partner for future growth, we will be your guide.

M&A

When the time comes, we’re by your side every step of the way. We help you evaluate your market, find the right buyer, and deliver the true value of your business.

Divestments

With a strong track record in company carve-outs, we can help you realign your portfolio and redeploy capital to the growth of your core business.

Licensing

We support clients with in-licensing, out-licensing, drug licensing, and facility licensing and we understand the complexities that are unique to licensing deals.

Equity Fundraising

We understand that optimising terms is critical, but so is finding the right partner for growth. We help articulate your equity story, target the best investors and negotiate the right deal.

Strategic Advice

Having completed over 300 transactions, we bring the breadth of perspectives and depth of business experience to provide advice on strategic options for businesses.

Recent Deals

Jan 2022
has divested its API manufacturing site in Cramlington, UK, to
Jan 2022
A Beech Tree Private Equity-backed company
has received investment from
Jan 2022
has invested in
Quorum Cyber
Nov 2021
has invested in
Nov 2021
has received a significant investment from
Nov 2021
has made an investment in
company name confidential
Oct 2021
has been acquired by
Aug 2021
has merged with
a Vespa Capital-backed company
Aug 2021
has been acquired by
an Odyssey Investment Partners-backed company
Aug 2021
a Sovereign Capital Partners-backed company
has acquired

Results. Great people creating great outcomes, together.

Latest Insights

Reports
10th November 2021

CDMO Market Update

We are pleased to share with you the CDMO Market Update – November 2021, where we analyse global M&A activity and public market valuations in the CDMO sector. H1 2021 was an exceptional start to the year with 48 deals in total in the CDMO sector, almost reaching the total annual transactions in the previous four […]

Reports
3rd November 2021

Marketing Services: Global M&A and Public Company Performance Q3 2021

We are pleased to share with you the Q3 2021 Marketing Services Sector Review, where we analyse global M&A activity and public market performance in the marketing services sector. The M&A market for Marketing Services remains buoyant and dynamic with Q1-Q3 2021 deal volume up by 30% on the comparative period at 569 and 441 […]

Reports
19th October 2021

The Technology Services Perspective – Q3 2021

Deal activity this quarter continues to be driven by strong confidence in acquiring capability in next-gen, modernisation and cloud-first tech stacks, and premium services. Equally, capturing the end-to-end digital transformation value chain continues to be a key M&A theme to become the strategic operator and engineering partner of choice for large-scale budgets. Public tech companies […]